Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Hepatitis

Free Subscription 09.03.2026 2 Gut 1 J Med Virol 5 J Viral Hepat 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Gut

1. WU W, Gao Q, Hai S, Li X, et al
   Impairment of Rab7-dependent STING degradation hampers HBV replication but accelerates disease progression in chronic hepatitis B comorbid with MASLD.
   Gut. 2026 Mar 3:gutjnl-2026-338065. doi: 10.1136/gutjnl-2026-338065.
   PubMed         Abstract available
   
   
2. WENG D, Chen J, Lin C
   Absolute risk stratification of HCC after HCV cure in MASLD: do advanced steatosis and dysglycaemia add beyond liver stiffness?
   Gut. 2026 Mar 2:gutjnl-2026-338294. doi: 10.1136/gutjnl-2026-338294.
   PubMed        
   
   

   
   J Med Virol

3. TOYODA H, Nozaki A, Hiraoka A, Itobayashi E, et al
   Changes in the Liver Fibrosis of Patients Who Develop Hepatocellular Carcinoma After a Sustained Virologic Response to Hepatitis C Virus Infection.
   J Med Virol. 2026;98:e70865.
   PubMed         Abstract available
   
   

   
   J Viral Hepat

4. JANG TY
   The Impact of Ambient Temperature on HCC Risk in Patients With Chronic Hepatitis B.
   J Viral Hepat. 2026;33:e70166.
   PubMed        
   
   
5. THOMADAKIS C, Gountas I, Gountas K, Nuno N, et al
   Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence Synthesis.
   J Viral Hepat. 2026;33:e70159.
   PubMed         Abstract available
   
   
6. DEMANT J, Soholm J, Lazarus JV, Krohn-Dehli L, et al
   Prevalence and Factors Associated With Hepatitis C in Danish Prisons, 2022-2024: A Multicentre Cross-Sectional Study.
   J Viral Hepat. 2026;33:e70154.
   PubMed         Abstract available
   
   
7. NIYOMSRI S, Lim AG, Arif A, Asim M, et al
   The Impact of Hepatitis C and Socio-Demographic Variables on Health-Related Quality of Life in Pakistan: Cross-Sectional Study.
   J Viral Hepat. 2026;33:e70139.
   PubMed         Abstract available
   
   
8. LI J, Xu X, Liu J, Li M, et al
   Prevalence, Clinical Presentation and Outcome of Hepatitis B Patients With Indeterminate Phase: A Systematic Review and Meta-Analysis.
   J Viral Hepat. 2026;33:e70161.
   PubMed         Abstract available
   
   

   
   PLoS One

9. SHOYEMI E, Aghedo OG, Obi C, Uwaoma CPK, et al
   Impact of demographic factors and HIV status on Hepatitis B vaccination adherence and completion rate among high-risk populations in Lagos State, Nigeria.
   PLoS One. 2026;21:e0321434.
   PubMed         Abstract available
   
   

   
   Proc Natl Acad Sci U S A

10. JU X, Dong L, Liu T, Zhang F, et al
    EIF4H and YBX1 are essential host factors for hepatitis E virus replication and pathogenesis.
    Proc Natl Acad Sci U S A. 2026;123:e2529289123.
    PubMed         Abstract available
    
    

    
    Transplant Proc

11. KHURANA S, Gaines S, Kumarjiguda D, Kotru A, et al
    In Hepatitis C Virus-Negative Recipients of a Hepatitis C Virus-Infected Donor Kidney, Direct Antiviral Agent Therapy for 8 Weeks Is Noninferior to 12 Weeks.
    Transplant Proc. 2026 Mar 4:S0041-1345(26)00097.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum